Northern Trust’s Cytokinetics CYTK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$45.6M Sell
1,379,191
-68,125
-5% -$2.25M 0.01% 1155
2025
Q1
$58.2M Sell
1,447,316
-24,173
-2% -$972K 0.01% 1006
2024
Q4
$69.2M Buy
1,471,489
+141,835
+11% +$6.67M 0.01% 931
2024
Q3
$70.2M Buy
1,329,654
+46,761
+4% +$2.47M 0.01% 819
2024
Q2
$69.5M Buy
1,282,893
+171,453
+15% +$9.29M 0.01% 802
2024
Q1
$77.9M Buy
1,111,440
+55,463
+5% +$3.89M 0.01% 735
2023
Q4
$88.2M Sell
1,055,977
-17,268
-2% -$1.44M 0.02% 671
2023
Q3
$31.6M Sell
1,073,245
-26,088
-2% -$769K 0.01% 1244
2023
Q2
$35.9M Buy
1,099,333
+88,408
+9% +$2.88M 0.01% 1192
2023
Q1
$35.6M Buy
1,010,925
+128
+0% +$4.5K 0.01% 1171
2022
Q4
$46.3M Buy
1,010,797
+18,446
+2% +$845K 0.01% 969
2022
Q3
$48.1M Buy
992,351
+20,685
+2% +$1M 0.01% 885
2022
Q2
$38.2M Buy
971,666
+6,879
+0.7% +$270K 0.01% 1059
2022
Q1
$35.5M Sell
964,787
-44,558
-4% -$1.64M 0.01% 1277
2021
Q4
$46M Sell
1,009,345
-595
-0.1% -$27.1K 0.01% 1165
2021
Q3
$36.1M Buy
1,009,940
+102,360
+11% +$3.66M 0.01% 1344
2021
Q2
$18M Buy
907,580
+97,399
+12% +$1.93M ﹤0.01% 1957
2021
Q1
$18.8M Sell
810,181
-27,276
-3% -$634K ﹤0.01% 1863
2020
Q4
$17.4M Sell
837,457
-40,479
-5% -$841K ﹤0.01% 1888
2020
Q3
$19M Buy
877,936
+82,571
+10% +$1.79M ﹤0.01% 1668
2020
Q2
$18.7M Buy
795,365
+22,057
+3% +$520K ﹤0.01% 1676
2020
Q1
$9.12M Buy
773,308
+7,900
+1% +$93.1K ﹤0.01% 1929
2019
Q4
$8.12M Sell
765,408
-25,210
-3% -$267K ﹤0.01% 2315
2019
Q3
$9M Buy
790,618
+113,633
+17% +$1.29M ﹤0.01% 2216
2019
Q2
$7.62M Buy
676,985
+133,189
+24% +$1.5M ﹤0.01% 2318
2019
Q1
$4.4M Buy
543,796
+11,469
+2% +$92.8K ﹤0.01% 2634
2018
Q4
$3.36M Sell
532,327
-12,987
-2% -$82.1K ﹤0.01% 2748
2018
Q3
$5.37M Buy
545,314
+46,768
+9% +$461K ﹤0.01% 2646
2018
Q2
$4.14M Buy
498,546
+71,418
+17% +$593K ﹤0.01% 2785
2018
Q1
$3.08M Buy
427,128
+675
+0.2% +$4.86K ﹤0.01% 2865
2017
Q4
$3.48M Sell
426,453
-45,405
-10% -$370K ﹤0.01% 2831
2017
Q3
$6.84M Buy
471,858
+4,546
+1% +$65.9K ﹤0.01% 2432
2017
Q2
$5.66M Buy
467,312
+86,885
+23% +$1.05M ﹤0.01% 2544
2017
Q1
$4.89M Buy
380,427
+5,645
+2% +$72.5K ﹤0.01% 2566
2016
Q4
$4.55M Buy
374,782
+18,235
+5% +$222K ﹤0.01% 2603
2016
Q3
$3.27M Buy
356,547
+52,561
+17% +$482K ﹤0.01% 2800
2016
Q2
$2.89M Sell
303,986
-113,203
-27% -$1.07M ﹤0.01% 2826
2016
Q1
$2.94M Buy
417,189
+43,846
+12% +$309K ﹤0.01% 2763
2015
Q4
$3.91M Buy
373,343
+23,191
+7% +$243K ﹤0.01% 2619
2015
Q3
$2.34M Buy
350,152
+17,175
+5% +$115K ﹤0.01% 2951
2015
Q2
$2.24M Buy
332,977
+2,102
+0.6% +$14.1K ﹤0.01% 3001
2015
Q1
$2.24M Buy
330,875
+1,164
+0.4% +$7.89K ﹤0.01% 3051
2014
Q4
$2.64M Sell
329,711
-17,837
-5% -$143K ﹤0.01% 2922
2014
Q3
$1.22M Buy
347,548
+2,513
+0.7% +$8.85K ﹤0.01% 3349
2014
Q2
$1.65M Sell
345,035
-2,004
-0.6% -$9.58K ﹤0.01% 3185
2014
Q1
$3.3M Sell
347,039
-4,692
-1% -$44.6K ﹤0.01% 2827
2013
Q4
$2.29M Buy
351,731
+13,569
+4% +$88.2K ﹤0.01% 3072
2013
Q3
$2.56M Buy
+338,162
New +$2.56M ﹤0.01% 2946